Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 328 of 5804
-
New hope for rare liver disease: drug aims to slow damage
Disease control Not yet recruitingLong-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a daily probiotic prevent iron deficiency in pregnancy?
Prevention Recruiting nowMaternal iron deficiency (ID) and iron deficiency anemia (IDA) is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate. Therefore, preventing maternal IDA in at-risk women is critical. …
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Could a brain pacemaker fight Alzheimer's? new trial begins.
Disease control Recruiting nowThe purpose of this study is to test a new procedure to treat Alzheimer's disease. The procedure is called intermittent Deep Brain Stimulation (DBS) of the nucleus basalis of Meynert. There will be up to six participants enrolled at Wellstar MCG Memory Clinic. There will be anoth…
Phase: PHASE1 • Sponsor: Augusta University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could stem cells shield kidneys after severe injury?
Disease control Recruiting nowThis study aims to investigate, through the collection of valid scientific evidence necessary to determine safety and effectiveness, the potential use of Allogeneic Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) to prevent progression of trauma-induced Acute …
Phase: PHASE1, PHASE2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a daily aspirin save lives after pneumonia in the elderly?
Disease control Not yet recruitingAcute pneumonia is a very common disease, and one of the leading causes of hospitalization and death in France. Almost a century after the discovery of penicillin, no major breakthrough has significantly reduced pneumonia-related mortality. While the choice of an appropriate anti…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC
-
Kenya project aims to eradicate cervical cancer with HPV vaccine and better screening
Prevention Not yet recruitingThis project serves to continue a community-based initiative, known as the Kenya Mother-Daughter Cervical Cancer Eradication Project, or the Mother-Daughter Project (MDP), in the Webuye region of Western Kenya. The MDP project, since its initiation in 2018, has sought to develop …
Phase: NA • Sponsor: Indiana University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Could a daily brain zapping helmet ease autism symptoms in kids?
Symptom relief Not yet recruitingThis study will test whether a noninvasive brain stimulation treatment called Functional Neurogenesis Stimulation (using the NeuroCytontron device) can safely improve core symptoms of Autism Spectrum Disorder (ASD) in children. The study will enroll boys and girls 3 to 12 years o…
Phase: NA • Sponsor: Neurocytonix, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New trial matches liver cancer treatment to Tumor's Fat-Burning signature
Disease control Not yet recruitingThis study is a prospective, multicenter Phase II trial evaluating a personalized treatment strategy for patients with unresectable hepatocellular carcinoma (HCC). The study uses a metabolic classification system called the fatty acid degradation (FAD) subtype to guide therapy se…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Immunotherapy plus chemo shows promise in shrinking HPV throat tumors before surgery
Disease control Recruiting nowThis is a single-center phase 2 study of to test how well the combination of toripalimab with chemotherapy followed by TORS or risk and response stratified de-escalated (chemo)radiotherapy works in patients with in HPV16+ locoregionally advanced oropharyngeal cancer (OPC).
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New breathing support could save tiny lungs
Disease control Not yet recruitingRespiratory Distress Syndrome (RDS) remains the most common respiratory complication in the early postnatal period among preterm infants born before 32 weeks' gestational age. For this population, implementing lung-protective ventilation strategies is essential to shorten the dur…
Phase: NA • Sponsor: Xingwang Zhu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingA Randomized, Non-comparative, Multicenter Phase II Clinical Trial of Becotatug Vedotin Combined with or without Immune Checkpoint Inhibitors (Penpulimab/Ivonescimab) in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LAHNSCC). This…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug cocktail aims to shrink breast tumors before surgery
Disease control Recruiting nowThis study is a prospective, multi-cohort, multicenter, open-label exploratory clinical trial. The primary study objective is to evaluate the pathologic complete response (PCR) of treatment of HR+/HER2-low breast cancer with neoadjuvant therapy combined with Trastuzumab Rezetecan…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Radiation plus immunotherapy: a new hope for rectal cancer patients?
Disease control Not yet recruitingThis study aims to evaluate the efficacy (pathological complete response rate) of short-course radiotherapy with preservation of tumor-draining lymph nodes followed by sequential PD-1 inhibitor neoadjuvant therapy in patients with stage II-III pMMR/MSS locally advanced rectal can…
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy aims to shrink Hard-to-Treat colorectal tumors before surgery
Disease control Not yet recruitingThis phase II clinical trial evaluates the efficacy and safety of three neoadjuvant regimens in patients with locally advanced microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) colorectal cancer (CRC): 1) Regimen A: Dual immune checkpoint blockade with nivolu…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Liver cancer surgery Follow-Up: could a targeted chemo shot keep cancer away?
Disease control Recruiting nowThe 5-year recurrence rate after curative hepatectomy of hepatocellular carcinoma (HCC) remains as high as 70%. According to the Chinese Liver Cancer Staging (CNLC), transarterial chemoembolization (TACE) is strongly recommended as an adjuvant therapy after curative hepatectomy, …
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart-Saving pills? diabetes drugs tested to shield breast cancer patients from chemo damage
Prevention Not yet recruitingBackground: Breast cancer is the most frequently diagnosed malignancy among women worldwide and a major cause of morbidity and mortality. Anthracycline-based chemotherapy, particularly doxorubicin, remains a cornerstone of treatment; however, its clinical utility is limited by d…
Phase: PHASE4 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Fasting diet and exercise may boost chemo in aggressive breast cancer
Disease control Recruiting nowLESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves t…
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Stent before surgery slashes deadly leak risk in colon patients
Prevention Recruiting nowRationale: Anastomotic leakage (AL) is a severe complication of colon surgery, with an incidence of 2.7-11.9%. It is associated with long-term increased mortality, reduced quality of life, and high healthcare costs due to reoperations and prolonged hospitalization. Among colon c…
Phase: NA • Sponsor: Medisch Spectrum Twente • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New hope for drug-resistant lung cancer: combo therapy enters trial
Disease control Recruiting nowEfficacy and Safety of Sacituzumab Tirumotecan Combined with Furmonertinib in Patients with Locally Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC